JPMorgan, Four Corners Racing’s Anthony Trimarchi Joins Writers’ Room

It was an eventful few days for racing in the northeast, and the TDN Writers' Room presented by JPMorgan Private Bank broke down all of the latest developments in the Monmouth jockey standoff and the raids on Parx barns by the Pennsylvania Racing Commission Wednesday morning. Plus, they welcomed Four Corners Racing's managing partner Anthony Trimarchi as the Green Group Guest of the Week to discuss his experiences as a new owner in the game and the economics of racing from a banking perspective.

“I was exposed to racing at a real young age because I grew up in Albany, just south of Saratoga,” Trimarchi said of his history in the game. “Every year of my life, I would spend a day at the races with my extended family in the backyard at Saratoga and hanging out at the picnic area at the top of the stretch. I loved going to the track as a kid for the same reasons I love it today. It's an amazing, outdoor sport with beautiful horses, excitement, competition, crowds, numbers, colors. As I got older, I kept going, introducing a bunch of college friends to Saratoga. I had my bachelor party at the Travers in 2010. Fast forward to today, I've been involved on the ownership side for about five years and it's all come full circle for me because I've taken my kids to the track. I've got three elementary school-age children who have all been in the paddock at Belmont, Saratoga and Aqueduct. They've been in the winner's circle at Oaklawn Park. I just hope that they'll have the same fond memories that I have from when I was a kid, and I can't wait to make new memories with them over the next 10, 20, 30 years.”

Also a managing director at JPMorgan Private Bank, Trimarchi was asked from an economic standpoint why he thinks racing has struggled to find new owners despite skyrocketing purses over the last decade-plus.

“I think it's just all about exposure and awareness,” he said. “The purses are attractive if you structure your business the right way and have the right partners. And the shot of adrenaline that you get leading up to a race or when you win a race, I wish I could put that in a bottle because I'll be chasing that the rest of my life. The first time I was in the winner's circle, I decided I was going to own a horse. I saw the sport [initially] through clients who were major owners who had dozens of horses running all over the place. I didn't understand what entry [into the game] would look like. I thought it was the kind of thing you needed to be a billionaire to do. It's not. It requires some disposable income obviously, but you can do it responsibly and get exposure. I'm a great example of that. I started out doing small syndicate stuff, I saw the sport, I saw the risk, I understood it, and I decided I wanted to do more.”

Elsewhere in the show, which is also sponsored by Keeneland, West Point Thoroughbreds, the Minnesota Racehorse Engagement Project and Legacy Bloodstock, the writers questioned whether or not there would be any long-term consequences for Bob Baffert from the embarrassment of the Derby and looked forward to Memorial Day Weekend stakes action. Click here to watch the podcast; click here for the audio-only version.

The post JPMorgan, Four Corners Racing’s Anthony Trimarchi Joins Writers’ Room appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Baffert The Center Of Two More Civil Suits In Federal Court In Medina Spirit Case

Days after a group of four horseplayers filed suit against trainer Bob Baffert and Medina Spirit owner Zedan Racing over the expected disqualification of the horse from his Kentucky Derby win, Baffert has been named in two more similar federal lawsuits.

Both follow a similar premise to the May 13 civil suit filed by horseplayers Michael Beychok, Justin Wunderler, Michael Meegan and Keith Mauer. One was filed May 24 in U.S. District Court for the Central District of California by bettor Jeffrey Kaufman, who accuses Baffert and Zedan Racing of violating the Racketeer Influenced and Corrupt Organizations (RICO) Act due to the presence of a regulated substance, betamethasone, Baffert said he was informed was detected on the horse's post-race tests. The drug has yet to be confirmed in split-sample tests. Kaufman's suit alleges that Baffert's history of drug positives establishes a pattern and that his assurances to the public in late 2020 that he intended to improve barn procedures was trusted by bettors.

Kaufman's suit is also designed to be a class action on behalf of other bettors on the Kentucky Derby “who would have won their bets and winnings had Medina spirit been properly prohibiting from competing in the Kentucky Derby on May 1, 2021, or competed without the aid of an illegal drug.”

Kaufman requests, among other things, court-imposed restrictions on Baffert's “future activities in Thoroughbred racing.”

The Kaufman suit accuses Baffert and Zedan of violating the RICO Act, common law fraud, and equitable fraud, and Baffert alone of conspiring to violate California laws against racketeering. Baffert and Zedan have not yet filed responses.

Read that complaint here.

Another horseplayer, Florida-based Anthony Mattera, filed suit against Baffert and Churchill Downs in Jefferson Circuit Court in Kentucky based on the Medina Spirit drug positive, but that case was removed to the U.S. District Court for the Western District of Kentucky. Mattera claims, based on Baffert's history of drug violations, Churchill Downs should have refused his entry of Medina Spirit into the race and also that the track could have implemented its own pre-race testing procedures. (The Kentucky Horse Racing Commission already conducts pre-race testing for the Kentucky Derby and Kentucky Oaks.) Mattera also claimed the track should not have calculated the payouts based on the results with Medina Spirit as the winner.

Mattera also seeks to have his lawsuit recognized as a class action. Mattera's suit alleges negligence on the part of Baffert and Churchill, and violation of the Kentucky Consumer Protection Act and unjust enrichment by Churchill. Mattera seeks to permanently enjoin Churchill from conducting racing until it meets a number of conditions to screen horses pre-race, settle wagers that change as the result of disqualifications, and publicly disclose medical records among other things. Baffert and Churchill have not yet filed responses.

Read that complaint here.

The post Baffert The Center Of Two More Civil Suits In Federal Court In Medina Spirit Case appeared first on Horse Racing News | Paulick Report.

Source of original post

Clenbuterol Or Albuterol Found In Hair Tests In Six Of 10 Finalists For Friday’s $731,650 Sam Houston Futurity

Hair testing that detected the presence of clenbuterol or albuterol in a majority of the finalists in Friday night's $731,650 Sam Houston Futurity for 2-year-old Quarter Horses at Sam Houston Race Park in Houston, Texas, has cast a cloud of uncertainty over the Grade 2 race, the Paulick Report has learned.

Six of the 10 runners that qualified in the May 7-8 trials were found to have either clenbuterol or albuterol from hair samples that were taken May 15, a source with knowledge of the testing procedures told the Paulick Report. Two other horses' sample sizes were insufficient and two of the 10 tested clean, the source said. The test results by individual horses in the rich Futurity was not disclosed.

A second sample was taken from eight of the 10 horses (excluding the two that tested clean) on Wednesday, May 26, for re-testing.

Both clenbuterol and albuterol – classified by the Texas Racing Commission as Class 3 drugs with a severe Category A penalty – are prohibited in Texas for use in race horses of all breeds, in accordance with 16 TAC 319.3. Though they are bronchodilators designed to treat airway disease, both drugs can be misused for their steroidal effects that can increase lean muscle mass.

The decision to supplement plasma and urine testing with hair testing for the Sam Houston Futurity finalists was driven by the Texas Racing Commission, the source said. Robert Elrod, a spokesperson for the Texas Racing Commission, said he could not comment on the situation “because it is an open investigation.”

Track officials are said to be considering their options for the race, which is funded largely through a series of five nominations and sustaining payments that began in December 2019. The winner is slated to earn $292,660.

There are no also eligibles for the race, though positive drug tests are mentioned in the nomination form, which states: “Should a horse be disqualified for a positive drug test report or ineligibility of the horse according to the conditions of the race (i.e., age, breed, ringer, etc.) the next fastest qualifier shall assume the disqualified horse's position in the final.”

The post Clenbuterol Or Albuterol Found In Hair Tests In Six Of 10 Finalists For Friday’s $731,650 Sam Houston Futurity appeared first on Horse Racing News | Paulick Report.

Source of original post

Daring Tact Sustains Leg Injury, Out Until 2022

Japanese Fillies' Triple Crown Winner Daring Tact (Jpn) (Epiphaneia {Jpn}) has injured her right foreleg and will be sidelined for at least nine months, reported www.p.nikkansports.com. The 4-year-old filly was diagnosed with ligamentitis upon her return to Shiga Prefecture to quarantine after a trip to Hong Kong, according to Makio Okada of Okada Stud Group. Daring Tact will return to Normandy Farm to recover.

“She was diagnosed and will require nine-months off to heal,” said Okada. “It's not good to overdo it. If you overdo it, the range of motion will be narrow. Because it is [Daring Tact we are dealing with] I want to heal it firmly over time. I think she will be back next April.”

Trained by Haruki Sugiyama, the bay rattled off victories in G1 Japanese 1000 Guineas last April, the G1 Japanese Oaks a month later, and the G1 Japanese Fillies' St Leger in October. Although winless since, the Normandy Thoroughbred Racing colourbearer was a very good third in the Nov. 29 G1 Japan Cup in the wake of Japanese Horse of the Year Almond Eye (Jpn) (Lord Kanaloa {Jpn}) and 2020 Triple Crown Winner Contrail (Jpn) (Deep Impact {Jpn}). Resuming on Mar. 14, she ran second in the G2 Kinko Sho at Chukyo and ran third at Sha Tin in Hong Kong on Apr. 25.

The post Daring Tact Sustains Leg Injury, Out Until 2022 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights